Alfred Ngaw

Alfred Ngaw is a seasoned professional in medical affairs with extensive experience across various leadership roles in the biopharmaceutical industry. Currently serving as Senior Director of Strategic Operations in Medical Affairs at BridgeBio since February 2024, Alfred previously held notable positions as Senior Director of Medical Information at Heron Therapeutics, Inc. and Director of Medical Information and Education at Atara Biotherapeutics. Additional experience includes directorship roles at Adamas Pharmaceuticals and involvement in medical information for North American oncology at Medivation prior to its acquisition by Pfizer. Alfred's career began in medical affairs at Gilead Sciences, encompassing various managerial positions, and includes foundational clinical experience as a Clinical Pharmacist at UCSF Medical Center and a Pharmacy Practice Resident at the Department of Veterans Affairs. Educational qualifications comprise a PharmD from the University of California, San Francisco, an MBA from Golden Gate University, and a BS in Biochemistry from the University of California, Davis.